Skip to main content

Table 1 Summary of data arising from experiments utilizing 'omics' technologies.

From: Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms

Study

(Compartment)

I

(Plasma)

II

(Plasma)

III

(Plasma)

IV

(Plasma)

V

(Tissue)

VIa

(Tissue)

VIb

(Plasma)

VIIa

(Tissue)

VIIb

(Plasma)

Disease area

Organ

Toxicity

Cardio-vascular

Disease

Infectious Disease

Neuro-muscular Disease

Organ Toxicity

Organ Toxicity

Organ Toxicity

Species

Human

Human

Mouse

Mouse

Rat

Rat

Rat

Platforms

- GC/MS

   

  

- Lipid LC/MS

- Polar LC/MS

- Proteomics

(Mass Spectrometry)

  

- Proteomics

(Multiplexed Immunoassay)

 

      

  1. The metabolomic platforms utilized in various studies include GC/MS (gas chromatography coupled with mass spectrometry), Lipid LC/MS (liquid chromatography coupled with mass spectrometry platform targeting lipids) and Polar LC/MS (liquid chromatography coupled with mass spectrometry platform targeting polar metabolites).